Item 7.01 Regulation FD Disclosure
OnMarch 23, 2023 ,Biohaven Ltd. published an updated investor presentation (the "Presentation") to its website. A copy of the Presentation is attached as Exhibit 99.1 to this Current Report on Form 8-K, and is incorporated herein by reference. The information in this Current Report on Form 8-K, including the information set forth in Exhibit 99.1, is being furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits Exhibit Number* Exhibit Description 99.1 Investor Presentation, datedMarch 2023 104 The cover page of this Current Report on
Form 8-K formatted as Inline
XBRL.
* The XBRL instance document does not appear in the interactive data file because its XBRL tags are embedded within the inline XBRL document.
2
--------------------------------------------------------------------------------
© Edgar Online, source